Oscar Health, Inc. Financials

Market Capitalization $3.55 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-13.65
Forward PE	24.36
Price to Sales TTM	$0.43
Price to Book MRQ	$2.90
Enterprise to Revenue	0.25
Enterprise to EBITDA	46.13

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	0.35%
Operating Margin	-2.00%
Return on Assets TTM	0.21%
Return on Equity TTM	2.83%

Income Statement

Revenue TTM	$8,215,223,808
Revenue per Share TTM	$34.94
Quarterly Revenue Growth	68.30%
Gross Profit TTM	$0
EBITDA	$43,873,000
Net Income to Common TTM	$28,949,000
Diluted EPS TTM	$-0.02
Quarterly Earnings Growth YoY	68.30%

Balance Sheet

Total Cash MRQ	$1,709,928,960
Total Cash per Share MRQ	$6.92
Total Debt MRQ	$
Total Debt to Equity MRQ	31.14
Current Ratio MRQ	0.80
Book Value per Share MRQ	$4.71

Cash Flow

Operating Cash Flow TTM	$928,241,024
Levered Free Cash Flow TTM	$1,438,652,800

OSCR Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	211,755,008
Float Shares	190,063,220
Avg 10 Volume	4,483,790
Avg 30 Volume	None
Shares Short	16,928,923
Short Ratio	3.24
Short % of Shares	8.35%
% Held by Insiders	3.08%
% Held by Institutions	87.53%

Stock Price Summary

Beta	1.66
Fifty Two Week Low	$12.43
Fifty Two Week High	$23.79
Fifty Two Week Change	21.14%
Day 50 MA	$16.51
Day 200 MA	$17.40

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date